HealthDay News: Cancer
Lynparza Approved for Advanced Ovarian Cancer
FRIDAY, Dec. 19, 2014 (HealthDay News) -- Lynparza (olaparib)
has been approved by the U.S. Food and Drug Administration to treat
advanced ovarian cancer associated with defective BRCA genes, the
agency said Friday in a news release.
When the Cancer Patient Is a Pet You Love
FRIDAY, Dec. 12, 2014 (HealthDay News) -- The scourge of cancer
can strike peoples' four-legged friends, too, and an expert offers
tips to spot the disease early so treatments can work best.